EcoDrugPlus

Folate Receptor Alpha

Ensembl ID : ENSEEUG00000013915
Gene Symbol: FOLR1
4 External references
203 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSEEUG00000015800
Gene Symbol: FSHR
4 External references
200 Possible Orthologues:

Free Fatty Acid Receptor 1

Ensembl ID : ENSEEUG00000003137
Gene Symbol: FFAR1
4 External references
76 Possible Orthologues:

Free Fatty Acid Receptor 2

Ensembl ID : ENSEEUG00000006808
Gene Symbol: FFAR2
3 External references
339 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSEEUG00000000884
Gene Symbol: FRK
1 External references
217 Possible Orthologues:

Galactosidase Alpha

Ensembl ID : ENSEEUG00000015679
Gene Symbol: GLA
1 External references
197 Possible Orthologues:

Galectin 3

Ensembl ID : ENSEEUG00000013917
Gene Symbol: LGALS3
1 External references
219 Possible Orthologues:

Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha2

Ensembl ID : ENSEEUG00000007643
Gene Symbol: GABRA2
1 External references
201 Possible Orthologues:

Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha3

Ensembl ID : ENSEEUG00000007070
Gene Symbol: GABRA3
3 External references
198 Possible Orthologues:

Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha4

Ensembl ID : ENSEEUG00000010508
Gene Symbol: GABRA4
4 External references
200 Possible Orthologues:

Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha5

Ensembl ID : ENSEEUG00000011807
Gene Symbol: GABRA5
1 External references
265 Possible Orthologues:

Gamma-Aminobutyric Acid Type A Receptor Subunit Beta1

Ensembl ID : ENSEEUG00000014904
Gene Symbol: GABRB1
1 External references
100 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).